Company Access To Patient Info Would Require IRB Approval Under HHS Regs
Executive Summary
HHS' proposed privacy regs would require drug companies to obtain institutional review board approval in order to access individually identifiable patient information for research.
You may also be interested in...
HHS Privacy Regs Could Affect Firms' Product Support Services, BIO Says
HHS' proposed privacy rule should be amended to allow for information sharing by providers who call manufacturers' product support lines, BIO said in draft comments on the administration's proposal on the proper handling of medical records.
HHS Privacy Regs Could Affect Firms' Product Support Services, BIO Says
HHS' proposed privacy rule should be amended to allow for information sharing by providers who call manufacturers' product support lines, BIO said in draft comments on the administration's proposal on the proper handling of medical records.
Fujisawa To Fund Medicine Shoppe Transplant Management Program
The Medicine Shoppe and Fujisawa will partner to conduct a disease management program for transplant patients using Health Hero Network's internet communication system.